Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm palifermin study for reduction of oral mucositis in non-Hodgkin lymphoma or multiple myeloma patients undergoing high-dose chemotherapy and autologous peripheral blood stem cell transplant
2005-004642-14Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of palifermin in stomatitis, sponsored by Amgen. Primary endpoints: Incidence of severe oral mucositis and Duration of severe oral mucositis. Started Dec 2005; status: completed.
02
Drugs
palifermin
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2005-004642-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004642-14.